Novel renal medullary carcinoma cell lines, UOK353 and UOK360, provide preclinical tools to identify new therapeutic treatments is a research paper published in Genes Chromosomes and Cancer (2020). On theSindex it has a DataRank of 0. It has been cited 17 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research
Grant: ZIA BC011028
Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research
Grant: ZIA BC011038
Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research
Grant: ZIA BC011089
Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research
Grant: ZIC BC011044
Intramural NIH HHS
Grant: Z01 BC011089
National Institutes of Health
Grant: 1ZIABC011028-09
Clinical Studies of the Molecular Genetic Basis of Kidney Cancer
National Institutes of Health
Grant: 1ZIABC011038-16
Molecular Therapeutics of Kidney Cancer: VHL Gene and Fumarate Hydratase Gene
NCATS Division of Preclinical Innovation
FWCI
1.04
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals